Xinhua News Agency, Wuhan, May 4 (Reporter Wang Xian) During the hospitalization of patients with new coronary pneumonia, the mortality rate of patients with good blood glucose control (blood glucose variability in the range of 3.9-10.0mmol / L) was 1.1%, and poor blood glucose control (blood glucose variability The upper limit of sexuality exceeds 10.0 mmol / L). The mortality rate is as high as 11%, and blood glucose control is closely related to the mortality rate of patients with new coronary pneumonia and type 2 diabetes. This research result of Wuhan University was recently published in the internationally renowned academic journal "Cell Metabolism", which provides research evidence for clinical treatment of patients with new coronary pneumonia and type 2 diabetes.
The research leader and director of Wuhan University School of Basic Medicine Li Hongliang said that the research team conducted a retrospective longitudinal multicenter study on 9663 confirmed cases of new coronary pneumonia in 19 hospitals in Hubei Province, and calculated the relationship between blood glucose control and the possibility of death. Correlation, revealing the diagnosis and treatment of patients with new coronary pneumonia and type 2 diabetes: Diabetics should control the symptoms of new coronary pneumonia, the use of antifungal drugs is twice that of non-diabetics, and the use of immunoglobulin needs to be about 4% higher. The dosage of hypertension needs to be doubled, and the frequency of inhaled oxygen, non-invasive ventilation and invasive ventilation is also significantly higher.
At the same time, studies have shown that blood glucose control is closely related to the prognosis of patients with new coronary pneumonia. "In the well-controlled blood glucose group, patients have a better prognosis, which means that blood glucose control is an effective adjunct to the treatment of patients with new coronary pneumonia." Li Hongliang said.
According to reports, existing studies have shown that the combination of hypertension, diabetes, cardiovascular disease, kidney damage and liver disease and other basic diseases is an important cause of death and poor recovery of patients with new coronary pneumonia. Diagnosis and treatment experience is extracted through big data and shared with the world in time, which is of reference value for humans to fight against the epidemic.